Mutations in BRCA1 do not appear to contribute significantly to the risk of prostate cancer progression, according to DNA ...

Merck & Co. has won U.S. Food and Drug Administration priority review for its application seeking expanded use of its blockbuster cancer drug Keytruda in certain patients with head and neck cancer.

Eli Lilly and Company, Johnson & Johnson, Pfizer, Merck & Co., Inc., and Novo Nordisk A/S are the five Pharmaceutical stocks to watch today, according to MarketBeat’s stock screener tool. These ...

Merck Life Science opens formulation & technology centre in Turbhe, Navi Mumbai: Our Bureau, Bengaluru Tuesday, February 25, ...

The partners will test Summit’s ivonescimab alongside Pfizer’s antibody-drug conjugates in hopes of finding “potentially ...

Ligand originated, structured, and invested $50 million and led a syndicate of co-investors who invested $25 million in ...

Detailed results presented at a medical congress help reinforce analyst expectations the drug, called duvakitug, will be competitive with other Crohn’s, colitis medicines in testing.

Excerpts from recent editorials in the United States and abroad: ___ Feb. 20 The Washington Post says Musk's mass firings are backfiring President Donald Trump and Elon Musk have been rapidly firing ...

The Dow Jones Industrial Average, which emerged stronger than the other two major indices this year, had its biggest weekly drop since October, losing 2.5%. The slide came amid renewed concerns about ...

A meeting held between President Donald Trump and top pharmaceutical executives showed some tensions over drug pricing policy, tariffs and manufacturing.

Viking advances VK2735 with a phase 2a study targeting results in H2'25. Phase 3 begins in Q2'25, fueling progress and ...